Literature DB >> 15112459

Current status of the utilization of antiepileptic treatments in mood, anxiety and aggression: drugs and devices.

John J Barry1, Anna Lembke, Kim D Bullock.   

Abstract

Interventions that have been utilized to control seizures in people with epilepsy have been employed by the psychiatric community to treat a variety of disorders. The purpose of this review will be to give an overview of the most prominent uses of antiepileptic drugs (AEDs) and devices like the Vagus Nerve Stimulator (VNS) and Transcranial Magnetic Stimulation (TMS) in the treatment of psychiatric disease states. By far, the most prevalent use of these interventions is in the treatment of mood disorders. AEDs have become a mainstay in the effective treatment of Bipolar Affective Disorder (BAD). The U.S. Food and Drug Administration has approved the use of valproic acid for acute mania, and lamotrigine for BAD maintenance therapy. AEDs are also effectively employed in the treatment of anxiety and aggressive disorders. Finally, VNS and TMS are emerging as possibly useful tools in the treatment of more refractory depressive illness.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15112459     DOI: 10.1177/155005940403500107

Source DB:  PubMed          Journal:  Clin EEG Neurosci        ISSN: 1550-0594            Impact factor:   1.843


  1 in total

1.  Brief report: retrospective case series of oxcarbazepine for irritability/agitation symptoms in autism spectrum disorder.

Authors:  Jessica F Douglas; Kevin B Sanders; M Hannah Benneyworth; Jessica L Smith; Virginia M Dejean; Susan G McGrew; Jeremy Veenstra-Vanderweele
Journal:  J Autism Dev Disord       Date:  2013-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.